The notices it replaced
- Reissues: RFA-DK-21-503 Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- 2 steps back: RFA-DK-16-508 Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,110,470 in first-year total cost, median $6,055,235.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-S (M4)]2
Most frequent institutions
- CASE WESTERN RESERVE UNIVERSITY2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Epidemiology of Diabetes Interventions and Complications (EDIC) Study2U01DK094157-12 · under RFA-DK-21-503 | BEBU, IONUTBRAFFETT, BARBARA HALINAGUBITOSI-KLUG, ROSE A | CASE WESTERN RESERVE UNIVERSITY, OH | $6,499,998 | ZDK1 |
| 2017 | Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)2U01DK094157-07 · under RFA-DK-16-508 | GUBITOSI-KLUG, ROSE A | CASE WESTERN RESERVE UNIVERSITY, OH | $5,610,472 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.